Integrity Alliance LLC. Invests $419,000 in The Clorox Company $CLX

Key Points

• Integrity Alliance LLC has acquired 2,845 shares of The Clorox Company, valued at approximately $419,000, as reported in their recent SEC filing.
• The Clorox Company increased its quarterly dividend to $1.24 per share, demonstrating a commitment to return value to shareholders and yielding 4.0% annually.
• Clorox's latest earnings report showed an EPS of $2.87, surpassing expectations, with a revenue increase of 4.5% year-over-year.

Integrity Alliance LLC. bought a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,845 shares of the company's stock, valued at approximately $419,000.

Several other institutional investors also recently bought and sold shares of the stock. Raymond James Financial Inc. increased its stake in shares of Clorox by 15.6% in the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company's stock worth $39,747,000 after purchasing an additional 36,352 shares during the period. OneDigital Investment Advisors LLC bought a new position in shares of Clorox in the first quarter worth about $247,000. Brown Miller Wealth Management LLC bought a new position in shares of Clorox in the first quarter worth about $399,000. Roman Butler Fullerton & Co. bought a new position in shares of Clorox in the first quarter worth about $400,000. Finally, Wedge Capital Management L L P NC increased its stake in shares of Clorox by 33.5% in the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company's stock worth $4,198,000 after purchasing an additional 7,159 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. JPMorgan Chase & Co. lifted their price objective on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research note on Monday, September 8th. Wells Fargo & Company dropped their price objective on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a research note on Friday, September 5th. UBS Group dropped their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research note on Thursday, July 17th. Morgan Stanley lowered their price target on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. Finally, Jefferies Financial Group lowered their price target on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Reduce" and a consensus price target of $142.18.

Clorox Price Performance

NYSE CLX traded up $1.97 during trading on Tuesday, reaching $124.79. 1,737,307 shares of the company traded hands, compared to its average volume of 1,666,903. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock's 50 day moving average price is $124.24 and its two-hundred day moving average price is $131.91. The company has a market cap of $15.26 billion, a price-to-earnings ratio of 19.14, a P/E/G ratio of 0.99 and a beta of 0.52. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the previous year, the business earned $1.82 EPS. Clorox's revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were paid a $1.24 dividend. This is an increase from Clorox's previous quarterly dividend of $1.22. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. Clorox's dividend payout ratio (DPR) is currently 76.07%.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company's stock, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.57% of the stock is currently owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.